Alessandra GraziottinJune 7, 2016
Anne GompelFebruary 19, 2019
Francesca Romana Grati, Italy
Francesca Romana Grati
is a Biologist, Clinical Laboratory Geneticists (ErCLG, European Board of Medical Genetics) with a Master degree in Human Pathology and Heredity. She is Chief Scientific Officer at TOMA, Advanced Biomedical Assays S.p.A. laboratory (Impact Lab Group).
She is currently member of the Board of Directors at International Society for Prenatal Diagnosis and therapy (ISPD), Chair of the Cytogenetics and cytogenomics working party of the Italian Society of Human Genetics (SIGU) and member of the editorial board of Prenatal Diagnosis journal.
Dr. Grati’s special interests are in prenatal diagnosis and fetal genetics. Her research is mainly focused on the understanding of the epidemiology of chromosome abnormalities in prenatal population, epigenetics of placenta, feto-placental mosaicisms and their impact on pre-implantation genetic screening, prenatal diagnosis and non-invasive prenatal testing. She is also committed to the evaluation of new clinical technologies, their setup and validation and to the implementation of clinical laboratory guidelines in practice as she believes that the education on Quality in the laboratories could reduce inequalities in care across the NHS. Dr. Grati has published extensively in the area of prenatal diagnosis and cfDNA-based screening and has served on committees that establish national prenatal care policy.